Andrés JM Ferreri

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 662 citations · Full text

Medicine, Oncology, Pharmacology +10

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Andrés JM Ferreri, Giuseppina Dognini, Elı́as Campo et al. · Haematologica · 2007 · 184 citations · Full text

Medicine, Hematology, Oncology +13

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Alexandar Tzankov, Zijun Y. Xu‐Monette, Marc Gerhard et al. · Modern Pathology · 2013 · 128 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Zijun Y. Xu‐Monette, Bouthaina S. Dabaja, Xiaoxiao Wang et al. · Modern Pathology · 2015 · 54 citations · Full text

Medicine, Hematology, Oncology +17

Association betweenHelicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications

Andrés JM Ferreri, Maurilio Ponzoni, Edi Viale et al. · Hematological Oncology · 2005 · 47 citations

Medicine, Infectious Diseases, Microbiology +15